F, L., & AD, I. (2026). Disproportionality analysis highlights paradoxical psoriasis as a clinically significant class effect of tumor necrosis-α inhibitors in pediatric populations. Pediatric research, 99(3), 837. https://doi.org/10.1038/s41390-025-04518-8
Chicago Style (17th ed.) CitationF, Lynch, and Irvine AD. "Disproportionality Analysis Highlights Paradoxical Psoriasis as a Clinically Significant Class Effect of Tumor Necrosis-α Inhibitors in Pediatric Populations." Pediatric Research 99, no. 3 (2026): 837. https://doi.org/10.1038/s41390-025-04518-8.
MLA (9th ed.) CitationF, Lynch, and Irvine AD. "Disproportionality Analysis Highlights Paradoxical Psoriasis as a Clinically Significant Class Effect of Tumor Necrosis-α Inhibitors in Pediatric Populations." Pediatric Research, vol. 99, no. 3, 2026, p. 837, https://doi.org/10.1038/s41390-025-04518-8.